NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Julia Haller
Wills Eye Hospital - Philadelphia / United States
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 4962748
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Julia Haller's MOST POPULAR ARTICLES
1-)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision … Age-Related Eye Disease Study Research Group Archives of ophthalmology 119 (10), 1417-1436, 2001 3888*2001
2-)
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration JM Seddon, UA Ajani, RD Sperduto, R Hiller, N Blair, TC Burton, ... Jama 272 (18), 1413-1420, 1994 21701994
3-)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trialS Russell, J Bennett, JA Wellman, DC Chung, ZF Yu, A Tillman, J Wittes, ...The Lancet 390 (10097), 849-860, 201712142017
4-)
Effects of medical therapies on retinopathy progression in type 2 diabetesACCORD Study Group and ACCORD Eye Study GroupNew England Journal of Medicine 363 (3), 233-244, 201016322010
5-)
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionJA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ...Ophthalmology 117 (6), 1134-1146. e3, 201013292010
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept